Abstract
The feasibility and accuracy of gene-specific molecular genetic diagnosis for congenital adrenal hyperplasia due to 21-hydroxylase deficiency was studied in a group of 24 pregnancies at 25% risk of carrying an affected fetus. Chorionic villus sampling was performed at 9–10 weeks' gestation. Southern analysis and polymerase chain reaction, followed by allele-specific hybridization for a panel of nine known mutations, were performed for each family. Mutations were identified in 95% of chromosomes examined; the molecular diagnosis was accurate in 96% of infants as confirmed by postnatal examination. The most common mutation identified was an A-to-G transition at base 656 in the second intron, the result of an apparent gene conversion. In one family, there had been a de novo mutation in intron 2, which was detected in the proband, but not in the mother or in the fetus. We conclude that first trimester prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency is feasible and accurate employing CYP21-specific probes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Collier S, Tassabehji M, Strachen T (1993) A de novo pathological point mutation at the 21-hydroxylase locus: implications for gene conversion in the human genome. Nature Genet 2:260–265
Coullin P, Nicolas H, Boue J, Boue A (1979) HLA typing of amniotic-fluid cells applied to prenatal diagnosis of congenital adrenal hyperplasia. Lancet I:1076
Donohoue PA, Van Dop C, McClean RH, White PC, Jospe N, Migeon C (1986) Gene conversion in salt-losing congenital adrenal hyperplasia with absent complement C4B protein. J Clin Endocrinol Metab 62:995–1002
Frasier SD, Thorneycroft IH, Weiss BA, Horton R (1975) Elevated amniotic fluid concentration of 17α-hydroxyprogesterone in congenital adrenal hyperplasia. J Pediatr 86:310–312
Gueux B, Fiet J, Couillin P, Raux-Demay M-C, Mornet E, Galons H, Villette J-M, Boue J, Dreux C (1988) Prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia by simultaneous radioimmunoassay of 21-deoxycortisol and 17-hydroxyprogesterone in amniotic fluid. J Clin Endocrinol Metab 66:534–537
Grosse-Wilde H, Valentin-Thon E, Vogeler U, Passarge E, Lorenzen F, Sippell W, Biedlingmaier F, Knorr D (1988) HLA-A, B, C, DR typing and 17-OHP determination for second trimester prenatal diagnosis of 21-hydroxylase deficient CAH, Prenat Diagn 8:131–143
Higashi Y, Tanae A, Inoue H, Fujii-Kiriyama Y (1988) Evidence for frequent gene conversion in the steroid 21-hydroxylase P450(C21) gene: Implications for steroid 21-hydroxylase deficiency. Am J Hum Genet 42:17–25
Jeffcoate TNA, Fleigner JRH, Russell SH, Davis JC, Wade AP (1965). Diagnosis of the adrenogenital syndrome before birth. Lancet II:553
Jeffreys AJ, Wilson V, Thein SL (1985) Hypervariable “minisatellite” regions in human DNA. Nature 314:67–73
McCreedy BJ, Callaway TH (1993) Laboratory design and work flow. In: Persing DH, Smith TF, Tenover FC, White TJ (eds) Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Wasthington, DC, pp 149–159
Merkatz IR, New MI, Seaman MP (1969) Prenatal diagnosis of adrenogenital syndrome by amniocentesis. J Pediatr 75:977–982
Morel Y, Murena M, Forest MG, Carel JC, Leger J, Nivelon J-L, David M (1993) Prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatr Res [Suppl] 33:S3
Mornet E, Boue J, Raux-Demay M, Couillin P, Oury JF, Dumez Y, Dausset J, Cohen D, Boue A (1986) First trimester prenatal diagnosis of 21-hydroxylase deficiency by linkage analysis of A-DNA probes and by 17-hydroxyprogesterone determination. Hum Genet 73:358–364
New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, Dupont B, Stoner E, Levy DJ, Pang S, Levine LS (1983) Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 57:320–326
Owerbach D, Crawford YM, Draznin MG (1990) Direct analysis of CYP21B genes in 21-hydroxylase deficiency using polymerase chain reaction amplification. Mol Endocrinol 4:125–131
Owerbach D, Ballard AL, Draznin MB (1992a) Salt-wasting congenital adrenal hyperplasia: detection and characterization of mutations in the steroid 21-hydroxylase (CYP21), using the polymerase chain reaction. J Clin Endocrinol Metab 74:553–558
Owerbach D, Draznin MB, Carpenter RJ, Greenberg F (1992b) Prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia using the polymerase chain reaction. Hum Genet 89:109–110
Pang S, Pollack MS, Loo M, Green O, Nussbaum R, Clayton G, Dupont B, New MI (1985) Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab 61:89–97
Pang S, Wallace MA, Hofman L, Thuline HC, Dorche C, Lyon ICT, Dobbins RH, Kling S, Fujeida K, Suwa S (1988) Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 81:866–874
Pollack MS, Maurer D, Levine LS, New MI, Pang S, Duchon M, Owens RP, Merkatz IR, Nitowsky HM, Sachs G, Dupont B (1979) Prenatal diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency) by HLA typing. Lancet I:1107
Rumsby G, Honour JW (1990) In vitro gene amplification for prenatal diagnosis of congenital adrenal hyperplasia. J Med Genet 27:676–678
Speiser PW, LaForgia N, Kato K, Pareira J, Khan R, Yang SY, Whorwood C, White PC, Elias S, Schriock E, Schriock E, Simpson JL, Taslimi M, Najjar J, May S, Mills G, Crawford C, New MI (1990) First trimester prenatal treatment and molecular genetic diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency). J Clin Endocrinol Metab 70:838–848
Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Lesser M, New MI, White PC (1992) Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 90:584–595
Strachan T (1990) Molecular pathology of congenital adrenal hyperplasia. Clin Endocrinol 32:373–393
Strachan T, Sinnott PJ, Smeaton I, Dyer PA, Harris R (1987) Prenatal diagnosis of congenital adrenal hyperplasia. Lancet II:1272–1273
Tusie-Luna MT, Speiser PW, Dumic M, New MI, White PC (1991) A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele. Mol Endocrinol 5:685–692
Weber JL, May PE (1989) Abundant class of human DNA polymorphism which can be typed using the polymerase chain reaction. Am J Hum Genet 44:388–396
White PC (1989) Analysis of mutations causing steroid 21-hydroxylase deficiency. Endocr Res 15:239–256
White PC, Vitek A, Dupont B, New MI (1988) Characterization of frequent deletions causing steroid 21-hydroxylase deficiency. Proc Natl Acad Sci USA 85:4436–4440
Wyman AR, White R (1980) A highly polymorphic locus in human DNA. Proc Natl Acad Sci USA 77:6754–6758
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Speiser, P.W., White, P.C., Dupont, J. et al. Prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency by allele-specific hybridization and Southern blot. Hum Genet 93, 424–428 (1994). https://doi.org/10.1007/BF00201668
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00201668